Thermo Fisher Scientific Inc. announced that on November 14, 2022 it priced an offering of €1.25 billion aggregate principal amount (the Offering) of the following euro-denominated notes: €500,000,000 aggregate principal amount of its 3.200% senior notes due 2026 (the 2026 notes), at the issue price of 99.965% of their principal amount, and €750,000,000 aggregate principal amount of its 3.650% senior notes due 2034 (the 2034 notes and together with the 2026 notes, the notes), at the issue price of 99.637% of their principal amount. The Offering is expected to close on or about November 21, 2022, subject to customary closing conditions. The notes will pay interest on an annual basis.